Our US Grantees

omar abdel wahab

Omar Abdel-Wahab, M.D.

Memorial Sloan-Kettering Cancer Center The Role of ASXL1 mutations in leukemia patients...more

patricia ernst

Patricia Ernst, Ph.D.

Dartmouth Medical School Targeting MLL-Cofactor Interaction to Selectively Block Mixed Lineage Leukemia...more

patrick brown

Patrick Brown, M.D.

Johns Hopkins, Sidney Kimmel Comprehensive Cancer Center Investigating promoter hypermethylation in the biology of MLL-rearranged leukemia, and as a novel...more

paul galardy

Paul J. Galardy, M.D.

Mayo Clinic Exploring the role of UCHL1 in leukemia and lymphoma...more

peiying yang

Pieying Yang, Ph.D.

MD Anderson Cancer Center Fish oil (n-3 fatty acids) and non-Hodgkin lymphoma...more

quingli

Qing Li, M.D., Ph.D.

Regents of the University of Michigan Nras signaling in hematopoietic stem cells and leukemic stem cells...more

richard harvey2

Richard C. Harvey, Ph.D.

University of New Mexico Cancer Research & Treatment Center...more

richard williams

Richard T. Williams, M.D., Ph.D.

St. Jude Children's Research Hospital Systematic, High-Throughput Developmental Therapeutics in High-Risk ALL...more

ronan swords

Ronan T. Swords, M.D.

Sylvester Comprehensive Cancer CenterUniversity of MiamiTargeting NEDD8 protein conjugation: a novel therapeutic strategy for acute lymphoblastic leukemia (ALL)....more

ross levine

Ross L. Levine, M.D.

Memorial Sloan-Kettering Cancer Center Genomic characterizations of myeloproliferative neoplasms...more

r oconnel

Ryan M. O'Connell, PhD

Assistant Professor University of Utah Investigating the collaboration between microRNAs and oncogenes in leukemia...more

parekh11

Samir Parekh, M.D.

Albert Einstein College of MedicineTargeting NOXA methylation to overcome Bortezomib resistance in MCL...more

samuel katz

Samuel Katz, MD, PhD

Yale School of Medicine Cell Death Regulation by Pro-Apoptotic BOK in Multiple Myeloma...more

sandra zinkel

Sandra S. Zinkel, M.D., Ph.D

Vanderbilt University School of Medicine The Role of Pro-apoptic BCL-2 Family Bid in the DNA Damage Response...more

sarah tasian

Sarah K. Tasian, MD

Children's Hospital of Philadelphia (CHoP) FLT3 Receptor-Redirected Chimeric Antigen Receptor T Call Immunotherapy for High Risk Pediatric Leukemias...more

scott armstrong

Scott A. Armstrong, M.D., Ph.D.

Children's Hospital, Dana Farber Cancer Institute Epigenetic Programs in MLL-rearranged leukemias...more

zha11

Shan Zha, M.D., Ph.D.

Columbia UniversityThe role of ATM kinase in suppression of B cell lymphomas...more

shari goldfarb

Shari Goldfarb, M.D.

Memorial Sloan-Kettering Cancer Center Reproductive and sexual concerns of young women treated for lymphoma, leukemia and breast cancer....more

maukherjee2

Siddhartha Mukherjee, M.D., Ph.D. (D. Phil)

Columbia University Medical Center Dissecting the roles of Yes-1, MIIt3 and Ctnnd1 in leukemia stem cell quiescence...more

Stephen X. Skapek, M.D.

Comer Children's Hospital Chicago Functional and Genetic Analysis of a Novel RB-Associated Transcriptional Repressor in Human Leukemia and Lymphoma...more